On Wednesday, lawyers for Elizabeth Holmes, the founder of the blood testing start-up Theranos, concluded their defense in her fraud trial.

attorney and a lead prosecutor, referring to the company’s investors and patients, who are at the heart of the fraud charges.

Holmes said.

Holmes, 37, faces 11 counts of fraud related to claims she made to investors and patients about Theranos, which collapsed in scandal in 2018.

Neama Rahmani, a former federal prosecutor and the president of the West Coast Trial Lawyers, said the pace of Ms.

Elizabeth Holmes, the disgraced founder of the blood testing start-up Theranos, stands trial for two counts of conspiracy to commit wire fraud and nine counts of wire fraud.

Kevin Downey, a partner at the Washington law firm Williams & Connolly, is the lead lawyer for Holmes.

She said she had concealed certain information about Theranos because it was a trade secret.

Holmes said it was difficult to separate where his influence began and ended.

She said she regretted adding the logos of pharmaceutical companies to validation reports that she had sent out to investors, which led them to believe that the drug companies had endorsed Theranos’s technology.

And she said she had allowed incorrect information to be disseminated in a positive Fortune cover article about her.

Holmes concluded a portion of her testimony with a speech about her intentions in pitching Theranos to investors, patients and the press.

Holmes, her lawyers said, made mistakes.

Holmes’s lawyers, said in his opening statement.

Holmes allowed false or misleading information about Theranos to spread to investors and patients.

They attacked the credibility of investors, trying to show that they should have done better research on Theranos before investing to understand the risks and the details of its business

And they tried to argue that patients who testified that they had received troubling blood test results from Theranos were not qualified to interpret them